Diagnostic and Evaluation of Hepato-pancreatico-biliary Disease With MRI
Diagnostik Und Evaluierung Hepato-pankreatiko-biliärer Erkrankungen Mittels Morphologischer Und Funktioneller Magnetresonanztomographie
1 other identifier
observational
2,000
1 country
1
Brief Summary
This is a retrospective review of images from patient data. There is no recruitment necessary for this study. Research Question: Can advanced multiparametric MRI techniques improve the detection and characterization of focal and diffuse liver disease, accurately assess treatment response and predict patient outcomes based on longitudinal monitoring? Hypotheses: Advanced multiparametric MRI techniques improve the detection, characterization and response assessment of focal and diffuse liver disease and can predict serious liver related outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2020
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 30, 2020
CompletedFirst Submitted
Initial submission to the registry
January 6, 2021
CompletedFirst Posted
Study publicly available on registry
January 8, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2023
CompletedJanuary 8, 2021
January 1, 2021
3.5 years
January 6, 2021
January 6, 2021
Conditions
Outcome Measures
Primary Outcomes (2)
Pathology findings in focal and/or diffuse liver disease
Pathology findings in focal and/or diffuse liver disease
1 year
Pathology findings in focal and/or diffuse pancreatic disease
Pathology findings in focal and/or diffuse pancreatic disease
1 year
Study Arms (2)
Liver disease
Pancreatic disease
Interventions
Advanced multiparametric MRI techniques to diagnose hepatic and pancreatic disease
Eligibility Criteria
Patients with suspicion for or diagnosed focal and/or diffuse liver or pancreatic disease who underwent MRI of the abdomen.
You may qualify if:
- Patients with suspicion for or diagnosed focal and/or diffuse liver or pancreatic disease who underwent MRI of the abdomen.
- years of age and older.
You may not qualify if:
- Age less than 18 years.
- Lack of MRI of the abdomen.
- Inadequate image quality.
- Documented rejection to participate in research studies
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital Zurich
Zurich, 8091, Switzerland
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Caecilia Reiner, MD
University of Zurich
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Staff Radiologist
Study Record Dates
First Submitted
January 6, 2021
First Posted
January 8, 2021
Study Start
June 30, 2020
Primary Completion
December 30, 2023
Study Completion
December 30, 2023
Last Updated
January 8, 2021
Record last verified: 2021-01
Data Sharing
- IPD Sharing
- Will not share